Skip to main content
SpringerLink
Log in

Mutational alterations of TDRD 1, 4 and 9 genes in colorectal cancers

  • Letter to the Editor
  • Published:
Pathology & Oncology Research

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jiang Y, Liu L, Shan W, Yang ZQ (2016) An integrated genomic analysis of Tudor domain-containing proteins identifies PHD finger protein 20-like 1 (PHF20L1) as a candidate oncogene in breast cancer. Mol Oncol 10:292–302

    Article  CAS  Google Scholar 

  2. Guijo M, Ceballos-Chávez M, Gómez-Marín E, Basurto-Cayuela L, Reyes JC (2017) Expression of TDRD9 in a subset of lung carcinomas by CpG island hypomethylation protects from DNA damage. Oncotarget 9:9618–9631

    Article  Google Scholar 

  3. Boormans JL, Korsten H, Ziel-van der Made AJ, van Leenders GJ, de Vos CV, Jenster G, Trapman J (2013) Identification of TDRD1 as a direct target gene of ERG in primary prostate cancer. Int J Cancer 133:335–345

    Article  CAS  Google Scholar 

  4. Yoon H, Lee H, Kim HJ, You KT, Park YN, Kim H, Kim H (2011) Tudor domain-containing protein 4 as a potential cancer/testis antigen in liver cancer. Tohoku J Exp Med 224:41–46

    Article  CAS  Google Scholar 

  5. Imai K, Yamamoto H (2008) Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 29:673–680

    Article  CAS  Google Scholar 

  6. Yoo NJ, Kim HR, Kim YR, An CH, Lee SH (2012) Somatic mutations of the KEAP1 gene in common solid cancers. Histopathology 60:943–952

    Article  Google Scholar 

  7. McGranahan N, Swanton C (2015) Biological and therapeutic impact of intratumor heterogeneity in cancer evolution. Cancer Cell 27:15–26

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by a grant from National Research Foundation of Korea (2019R1A5A2027588).

Author information

Author notes

    Authors and Affiliations

    1. Department of Pathology, College of Medicine, The CatholicUniversity of Korea, 505 Banpo-dong, Socho-gu, 137-701, Seoul, Korea

      Ha Yoon Mo, Eun Ji Choi, Nam Jin Yoo & Sug Hyung Lee

    2. Cancer Research Institute, College of Medicine, The Catholic University of Korea, 137-701, Seoul, Korea

      Sug Hyung Lee

    Authors
    1. Ha Yoon Mo
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Eun Ji Choi
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Nam Jin Yoo
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Sug Hyung Lee
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Sug Hyung Lee.

    Ethics declarations

    Conflict of interest

    None to declare.

    Additional information

    Publisher’s note

    Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

    Ha Yoon Mo and Eun Ji Choi contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Mo, H.Y., Choi, E.J., Yoo, N.J. et al. Mutational alterations of TDRD 1, 4 and 9 genes in colorectal cancers. Pathol. Oncol. Res. 26, 2007–2008 (2020). https://doi.org/10.1007/s12253-020-00798-z

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s12253-020-00798-z

    Search

    Navigation